Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995 / Edition 1

Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995 / Edition 1

by Louis Galambos
     
 

ISBN-10: 052162620X

ISBN-13: 9780521626200

Pub. Date: 08/28/1997

Publisher: Cambridge University Press

Networks of Innovation offers a historical perspective on the manner in which private sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp & Dohme, which acquired Mulford in 1929, and on Merck & Co., Inc.,

…  See more details below

Overview

Networks of Innovation offers a historical perspective on the manner in which private sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp & Dohme, which acquired Mulford in 1929, and on Merck & Co., Inc., which merged with Sharp & Dohme in 1953. By surveying a century of innovation in biologicals, the authors show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad.

Product Details

ISBN-13:
9780521626200
Publisher:
Cambridge University Press
Publication date:
08/28/1997
Edition description:
Reprint, 1st Paperback Edition
Pages:
273
Product dimensions:
5.98(w) x 8.98(h) x 0.79(d)

Table of Contents

Preface; 1. 1894: 'The foremost medical question of the day'; 2. The Mulford story; 3. A Sharp & Dohme interlude; 4. The virology network and a new programme at Merck, Sharp & Dohme; 5. Hilleman's innovations: first phase, measles-mumps-rubella; 6. Dangerous interlude, Marek's Disease adjuvant 65, the Swine Flu drama; 7. Transforming bacteriology: a second phase, meningitis, pneumonia, haemophilus, influenzae; 8. New networks, new leadership: the Hepatitis B vaccines; 9. Vaccine innovation in the nineties: new strategies, new structures, and public confrontations; A word about sources.

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >